Honebuto Draft Makes No Mention of Off-Year Re-Pricing or Buffer Zone, Calls for Stronger Drug Discovery Capabilities

The Japanese government unveiled a draft of its 2022 Basic Policy for Economic and Fiscal Management and Reform ( honebuto ) on May 31, but no mention was included for “off-year” drug re-pricing and the 2% buffer zone for price...read more